 "Aurobindo Pharma rallies on 1:1 bonus")
Shares of Aurobindo Pharma were trading higher by 5% at Rs 1,368 on the NSE after the company announced bonus shares in the ratio of 1:1 .i.e. one bonus equity share for every equity share held.
Meanwhile, the drug company reported 20% year-on-year drop in consolidated net profit to Rs 404 crore for the fourth quarter ended March 31, 2015 (Q4), as against a net profit of Rs 502 crore a year ago.
Total operating income, however, jumped by 36% to Rs 3,162 crore for the quarter, compared with Rs 2,330 crore for the same period a year ago.
EBIDTA or operating profit margins before foreign exchange gain/loss stood at 20.7% against 32% in the previous year quarter, Aurobindo Pharma said in a press release.
The stock opened at Rs 1,317 and touched a high of Rs 1,370 on the NSE. Till 0932 hours, a combined 616,512 shares changed hands on the counter on the NSE and BSE.
Meanwhile, the drug company reported 20% year-on-year drop in consolidated net profit to Rs 404 crore for the fourth quarter ended March 31, 2015 (Q4), as against a net profit of Rs 502 crore a year ago.
Total operating income, however, jumped by 36% to Rs 3,162 crore for the quarter, compared with Rs 2,330 crore for the same period a year ago.
EBIDTA or operating profit margins before foreign exchange gain/loss stood at 20.7% against 32% in the previous year quarter, Aurobindo Pharma said in a press release.
The stock opened at Rs 1,317 and touched a high of Rs 1,370 on the NSE. Till 0932 hours, a combined 616,512 shares changed hands on the counter on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%